Jump to content
RemedySpot.com

Increase in hyposapadias cannot be associated with Seroxat/Paxil

Rate this topic


Recommended Posts

Posted

Increase in hyposapadias cannot be associated with Seroxat/Paxil

seroxat sales freefall link

According to the Great Ormond Street Hospital for Children NHS Trust website, about one in every 300 boys has hypospadias, although this figure seems to be rising. It is not known why this figure is rising. So we have that grey area of whether or not paroxetine increases the chances of a male child being born with hypospadias. The Reis/Klln study seems to suggest that it does.

>> > > December 29th, 2010 by BOB FIDDAMAN> <http://ehealthforum.com/blogs/fiddy> [Pro]> > http://ehealthforum.com/blogs/fiddy/paxil-malformations-who-is-responsib\> le-b14405.html> <http://ehealthforum.com/blogs/fiddy/paxil-malformations-who-is-responsi\> ble-b14405.html>> > > <http://ehealthforum.com/health/jump_confirm.php?url=http://feedads.g.do\> ubleclick.net/~a/l4NGlcOLRPypQQff2L9fMA-CVjE/1/da>> > <http://ehealthforum.com/health/jump_confirm.php?url=http://3.bp.blogspo\> t.com/_4fq4nxa7Tqs/TRsZXEtthMI/AAAAAAAACIg/wEPvRIKU99o/s1600/MHRA.jpg>> > > A study from earlier this year by M. Reis and B. Klln showed that> paroxetine [brand names, Seroxat, Paxil and Aropax] seems to be> associated with a specific teratogenic property.> > The study was carried out because of concerns about possible adverse> effects of the use of antidepressant medication during pregnancy,> including risk for neonatal pathology and the presence of congenital> malformations.> > This particular study, entitled, "Delivery outcome after maternal use of> antidepressant drugs in pregnancy: an update using Swedish data", was> published in the Cambridge University Press early 2010.> > Data from the Swedish Medical Birth Register (MBR) from 1 July 1995 up> to 2007 were used to identify women who reported the use of> antidepressants in early pregnancy or were prescribed antidepressants> during pregnancy by antenatal care: a total of 14,821 women with 15,017> infants.> > The conclusion?> > > "Women using antidepressants during pregnancy and their newborns have> increased pathology. It is not clear how much of this is due to drug use> or underlying pathology. Use of TCAs was found to carry a higher risk> than other antidepressants and paroxetine seems to be associated with a> specific teratogenic property."> > Not so much of a conclusion really as it can be argued that is not clear> how much of this is due to drug use or underlying pathology - this is> the basis of arguments used in court rooms or 'negotiating tables' with> GlaxoKline's lawyers across the US.> > The majority of Paxil birth defect cases have been settled out of court,> the odd one or two have been lost by the claimants on legal> technicalities.> > The Reis/Klln study is quite significant in as much that it fingers> GSK's Paxil as not only being associated with a specific teratogenic> property, it also shows that pregnant patients taking Paxil increase the> chances of their babies being born with cardiovascular defects and> hypospadias.> > What is hypospadias?> > Hypospadias is a congenital (present at birth) problem affecting a boys> penis. It is a combination of three separate problems: the hole through> which urine passes (meatus) is not at the tip of the penis, the foreskin> is gathered at the back of the penis with none at the front and the> penis may be bent when stiff. The position of the meatus varies; in some> boys, the hole is only a small distance away from the tip of the penis,> whereas in others, it is at the base of the penis, in the scrotum or> behind the scrotum. [1]> > According to the Great Ormond Street Hospital for Children NHS Trust> website, about one in every 300 boys has hypospadias, although this> figure seems to be rising. It is not known why this figure is rising. So> we have that grey area of whether or not paroxetine increases the> chances of a male child being born with hypospadias. The Reis/Klln study> seems to suggest that it does.> > Who is responsible?> > So, the question, who is responsible falls into the pot. Do we point the> finger of blame at the manufacturer of Paxil, GlaxoKline or do we> scrutinise the body who regulate and license drugs in the UK, namely,> the MHRA?> > Even if blame is placed upon either of these two, who, or more> importantly, whom is responsible? What individual should take the blame> for allowing a known teratogen to be prescribed to pregnant patients?> > Surely, whomever it is, should be in a position to answer questions from> concerned members of the public, moreover, consumers of a product.> > The CEO of GlaxoKline is Witty. Should Witty go public and> offer an explanation as to why a drug manufactured by the company that> he heads could increase the chances of heart and hypospadias> malformations? It's one thing adding a warning to the ever increasing> [in text] patient information leaflet [PIL] - but is this really enough?> In any event, would this really be advisable considering GlaxoKline> are settling and defending many hundreds of Paxil birth defect trials in> America?> > Or do we expect more from the MHRA's CEO, Kent Woods?> > The MHRA's role is to protect the public from unsafe drugs. With> paroxetine top of their adverse reactions list, they could argue that> they are doing enough.> > The MHRA, like Glaxo, have half heartedly warned people of the risks of> taking paroxetine whilst pregnant. What they haven't done is label it a> teratogen. One would have thought that lessons were learned for the most> infamous teratogen of them all, Thalidomide, a drug that was mainly> prescribed to pregnant women for morning sickness in the late 50s and> early 60s. Instead the drug caused severe deformities in babies with> missing limbs.> > Are we on the brink of Dj Vu here?> > There is a fine line of protecting patients with regard to paroxetine> use. The MHRA tout the risk/benefit ratio and they, apparently, would> not want to alarm the public over paroxetine's propensity to cause> malformations because they are [still] of the opinion that the benefits> of taking paroxetine outweigh the risks.> > The Reis/Klln study would suggest otherwise.> > Wise up - pull the drug.> > The study is available for download [for a fee] HERE> <http://ehealthforum.com/health/jump_confirm.php?url=http://journals.cam\> bridge.org/action/displayAbstract?fromPage%3Donline%26aid%3D7878627>> >

Posted

Yuck

On 12/29/2010 8:54 AM, jeremy9282 wrote:

Increase in hyposapadias cannot be associated with Seroxat/Paxil

seroxat sales freefall link

According to

the Great Ormond Street Hospital for Children NHS Trust

website, about one in every 300 boys has hypospadias, although

this figure seems to be rising. It is not known why this

figure is rising. So we have that grey area of whether or not

paroxetine increases the chances of a male child being born

with hypospadias. The Reis/Klln study seems to suggest that it

does.

>

>

>

> December 29th, 2010 by BOB FIDDAMAN

> <http://ehealthforum.com/blogs/fiddy> [Pro]

>

>

http://ehealthforum.com/blogs/fiddy/paxil-malformations-who-is-responsib\

> le-b14405.html

>

<http://ehealthforum.com/blogs/fiddy/paxil-malformations-who-is-responsi\

> ble-b14405.html>

>

>

>

<http://ehealthforum.com/health/jump_confirm.php?url=http://feedads.g.do\

> ubleclick.net/~a/l4NGlcOLRPypQQff2L9fMA-CVjE/1/da>

>

>

<http://ehealthforum.com/health/jump_confirm.php?url=http://3.bp.blogspo\

>

t.com/_4fq4nxa7Tqs/TRsZXEtthMI/AAAAAAAACIg/wEPvRIKU99o/s1600/MHRA.jpg>

>

>

> A study from earlier this year by M. Reis and B. Klln

showed that

> paroxetine [brand names, Seroxat, Paxil and Aropax] seems

to be

> associated with a specific teratogenic property.

>

> The study was carried out because of concerns about

possible adverse

> effects of the use of antidepressant medication during

pregnancy,

> including risk for neonatal pathology and the presence of

congenital

> malformations.

>

> This particular study, entitled, "Delivery outcome after

maternal use of

> antidepressant drugs in pregnancy: an update using Swedish

data", was

> published in the Cambridge University Press early 2010.

>

> Data from the Swedish Medical Birth Register (MBR) from 1

July 1995 up

> to 2007 were used to identify women who reported the use of

> antidepressants in early pregnancy or were prescribed

antidepressants

> during pregnancy by antenatal care: a total of 14,821 women

with 15,017

> infants.

>

> The conclusion?

>

>

> "Women using antidepressants during pregnancy and their

newborns have

> increased pathology. It is not clear how much of this is

due to drug ! use

> or underlying pathology. Use of TCAs was found to carry a

higher risk

> than other antidepressants and paroxetine seems to be

associated with a

> specific teratogenic property."

>

> Not so much of a conclusion really as it can be argued that

is not clear

> how much of this is due to drug use or underlying pathology

- this is

> the basis of arguments used in court rooms or 'negotiating

tables' with

> GlaxoKline's lawyers across the US.

>

> The majority of Paxil birth defect cases have been settled

out of court,

> the odd one or two have been lost by the claimants on legal

> technicalities.

>

> The Reis/Klln study is quite significant in as much that it

fingers

> GSK's Paxil as not only being associated with a specific

teratogenic

> property, it also shows that pregnant patients taking Paxil

increase the

> chances of their babies being born with cardiovascular

defects and

> hypospadias.

>

> What is hypospadias?

>

> Hypospadias is a congenital (present at birth) problem

affecting a boys

> penis. It is a combination of three separate problems: the

hole through

> which urine passes (meatus) is not at the tip of the penis,

the foreskin

> is gathered at the back of the penis with none at the front

and the

> penis may be bent when stiff. The position of the meatus

varies; in some

> boys, the hole is only a small distance away from the tip

of the penis,

> whereas in others, it is at the base of the penis, in the

scrotum or

> behind the scrotum. [1]

>

> According to the Great Ormond Street Hospital for Children

NHS Trust

> website, about one in every 300 boys has hypospadias,

although this

> figure seems to be rising. It is not known why this figure

is rising. So

> we have that grey area of whether or not paroxetine

increases the

> chances of a male child being born with hypospadias. The

Reis/Klln s! tudy

> seems to suggest that it does.

>

> Who is responsible?

>

> So, the question, who is responsible falls into the pot. Do

we point the

> finger of blame at the manufacturer of Paxil,

GlaxoKline or do we

> scrutinise the body who regulate and license drugs in the

UK, namely,

> the MHRA?

>

> Even if blame is placed upon either of these two, who, or

more

> importantly, whom is responsible? What individual should

take the blame

> for allowing a known teratogen to be prescribed to pregnant

patients?

>

> Surely, whomever it is, should be in a position to answer

questions from

> concerned members of the public, moreover, consumers of a

product.

>

> The CEO of GlaxoKline is Witty. Should Witty go

public and

> offer an explanation as to why a drug manufactured by the

company that

> he heads could increase the chances of heart and

hypospadias

> malformations? It's one thing adding a warning to the ever

increasing

> [in text] patient information leaflet [PIL] - but is this

really enough?

> In any event, would this really be advisable considering

GlaxoKline

> are settling and defending many hundreds of Paxil birth

defect trials in

> America?

>

> Or do we expect more from the MHRA's CEO, Kent Woods?

>

> The MHRA's role is to protect the public from unsafe drugs.

With

> paroxetine top of their adverse reactions list, they could

argue that

> they are doing enough.

>

> The MHRA, like Glaxo, have half heartedly warned people of

the risks of

> taking paroxetine whilst pregnant. What they haven't done

is label it a

> teratogen. One would have thought that lessons were learned

for the most

> infamous teratogen of them all, Thalidomide, a drug that

was mainly

> prescribed to pregnant women for morning sickness in the

late 50s and

> early 60s. Instead the drug caused severe deformit! ies in

babies with

> missing limbs.

>

> Are we on the brink of Dj Vu here?

>

> There is a fine line of protecting patients with regard to

paroxetine

> use. The MHRA tout the risk/benefit ratio and they,

apparently, would

> not want to alarm the public over paroxetine's propensity

to cause

> malformations because they are [still] of the opinion that

the benefits

> of taking paroxetine outweigh the risks.

>

> The Reis/Klln study would suggest otherwise.

>

> Wise up - pull the drug.

>

> The study is available for download [for a fee] HERE

>

<http://ehealthforum.com/health/jump_confirm.php?url=http://journals.cam\

>

bridge.org/action/displayAbstract?fromPage%3Donline%26aid%3D7878627>

>

>

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...